PP_1170x120_10-25-21

hydromorphone HCI extended-release tablets

Perrigo set to ship generic version of Exalgo

DUBLIN, Ireland — Perrigo Co. plc has received approval from the Food and Drug Administration for hydromorphone HCI extended-release tablets (8 mg, 12 mg and 16 mg), an opioid pain medication. Perrigo said that it expects to begin shipments of the product to pharmacies within the next few weeks. The FDA concluded that Perrigo’s products

Adheris Health